In this Issue
CHIEF MEDICAL EDITOR’S PAGE
By Ted E. Feldman, MD, MSCAI, FACC, FESC
An appraisal of the available and potential device and technique options and treatment algorithms used to manage balloon undilatable lesions.
By Peter Tajti, MD; Iosif Xenogiannis, MD; Hatem Najar, MD; and Emmanouil S. Brilakis, MD, PhD
Customizing therapy in a new era.
By Yasuhiro Aoki, MD; and Joseph De Gregorio, MD
With improvements in technique and patient selection, operators can safely and successfully treat patients with chronic total occlusions, but further research is needed to better answer some areas of controversy.
By Megha Prasad, MD; and Jeffrey W. Moses, MD
A comprehensive CHIP program requires a true heart team approach, specialized operator skills and training, and institutional support and resources.
By Justin Levisay, MD
The role of thin-strut designs in the current generation of stent technology and the impact on clinical outcomes.
By Bernard Chevalier, MD
A summary of lessons learned from positive randomized trial data.
By Mohammad K. Mojadidi, MD; Muhammad O. Zaman, MD; Islam Y. Elgendy, MD, FACP, FESC; Ahmed N. Mahmoud, MD; and Jonathan M. Tobis, MD, FACC, MSCAI
A look at current and emerging nonpharmacologic stroke prevention therapies.
By Lluis Asmarats, MD; and Josep Rodés-Cabau, MD
After successful PMC, what do the results show at 20 years?
By Alec Vahanian, MD; and Bernard Iung, MD
Experts discuss the outcomes of the ABSORB trials and what the future may hold for bioresorbable scaffolds.
With Dean J. Kereiakes, MD, FACC, FSCAI; Ron Waksman, MD, FACC, FSCAI, FESC; James B. Hermiller Jr, MD, FACC, MSCAI; and Jarrod D. Frizzell, MD, FACC, SCAI
CODING & REIMBURSEMENT
A Q&A on the importance of considering an ambulatory surgical center or office-based lab to achieve your goals.